Explore
Validate
Learn
Western blotAntibody data
- Antibody Data
- Antigen structure
- References [5]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 16467-1-AP - Provider product page
- Provider
- Proteintech Group
- Product name
- GTF2B antibody
- Antibody type
- Polyclonal
- Description
- GTF2B antibody (Cat. #16467-1-AP) is a rabbit polyclonal antibody that shows reactivity with human and has been validated for the following applications: IP, WB,ELISA.
- Reactivity
- Human
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references Identification of RBX1 as a regulator of LIPT1 transcription and its role in copper-induced cell death in GBM cells.
Combinatorial ubiquitin code degrades deubiquitylation-protected substrates.
A novel TOX3-WDR5-ABCG2 signaling axis regulates the progression of colorectal cancer by accelerating stem-like traits and chemoresistance.
Melatonin synergizes BRAF-targeting agent vemurafenib in melanoma treatment by inhibiting iNOS/hTERT signaling and cancer-stem cell traits.
Targeting NF-κB/AP-2β signaling to enhance antitumor activity of cisplatin by melatonin in hepatocellular carcinoma cells.
Zeng J, Liu J, Hua S, Liu S, Tong S, Zhang J, Mungur R, Chen S, Feng J, Ding C
Scientific reports 2026 Jan 31;16(1):6837
Scientific reports 2026 Jan 31;16(1):6837
Combinatorial ubiquitin code degrades deubiquitylation-protected substrates.
Morita M, Takao M, Tokuhisa H, Chiba R, Tomomatsu S, Akizuki Y, Tomita T, Endo A, Saeki Y, Sato Y, Ohtake F
Nature communications 2025 Mar 24;16(1):2496
Nature communications 2025 Mar 24;16(1):2496
A novel TOX3-WDR5-ABCG2 signaling axis regulates the progression of colorectal cancer by accelerating stem-like traits and chemoresistance.
Hao J, Huang J, Hua C, Zuo Y, Yu W, Wu X, Li L, Xue G, Wan X, Ru L, Guo Z, Han S, Deng W, Lin F, Guo W
PLoS biology 2023 Sep;21(9):e3002256
PLoS biology 2023 Sep;21(9):e3002256
Melatonin synergizes BRAF-targeting agent vemurafenib in melanoma treatment by inhibiting iNOS/hTERT signaling and cancer-stem cell traits.
Hao J, Fan W, Li Y, Tang R, Tian C, Yang Q, Zhu T, Diao C, Hu S, Chen M, Guo P, Long Q, Zhang C, Qin G, Yu W, Chen M, Li L, Qin L, Wang J, Zhang X, Ren Y, Zhou P, Zou L, Jiang K, Guo W, Deng W
Journal of experimental & clinical cancer research : CR 2019 Feb 4;38(1):48
Journal of experimental & clinical cancer research : CR 2019 Feb 4;38(1):48
Targeting NF-κB/AP-2β signaling to enhance antitumor activity of cisplatin by melatonin in hepatocellular carcinoma cells.
Hao J, Li Z, Zhang C, Yu W, Tang Z, Li Y, Feng X, Gao Y, Liu Q, Huang W, Guo W, Deng W
American journal of cancer research 2017;7(1):13-27
American journal of cancer research 2017;7(1):13-27
No comments: Submit comment
No validations: Submit validation data